Skip to main content

Table 2 Summary of reported AIDS-defining illnesses (ADI) by year of HAART initiation

From: Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study

ERA (n)

1996-98

(967)

1999-01

(897)

2002-04

(783)

2005-07

(1074)

Total

(3721)

p-value

Any ADI (%)

44

(4.5)

50

(5.6)

61

(7.8)

59

(5.5)

214 (5.75)

0.181

Kaposi's Sarcoma (%)

7 (0.7)

10 (1.1)

13 (1.7)

12 (1.1)

42 (1.1)

0.295

Pnemocystis jirovecii pneumonia (%)

12 (1.2)

8 (0.9)

7 (0.9)

9 (0.8)

36 (0.97)

0.386

Non-Hodgkin's Lymphoma (%)

9 (0.9)

9 (1.0)

6 (0.8)

8 (0.7)

32 (0.86)

0.552

Mycobacterium avium intracellae (%)

6 (0.6)

6 (0.7)

11 (1.4)

5 (0.5)

28 (0.75)

0.971

HIV Wasting Snydrome (%)

3 (0.3)

3 (0.3)

6 (0.8)

8 (0.7)

20 (0.54)

0.103

Mycobacterium Tuberculosis (%)

0 (0)

7 (0.8)

4 (0.5)

4 (0.4)

15 (0.40)

0.363

Cryptococcal Meningitis (%)

3 (0.3)

2 (0.2)

5 (0.6)

3 (0.3)

13 (0.35)

0.785

  1. n = number who initiated HAART in each period